Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Single-Use Device Reuse Policy Expected To Solidify By Mid-2000

This article was originally published in The Gray Sheet

Executive Summary

FDA's Center for Devices and Radiological Health plans to extend regulatory authority over reprocessing of single use devices (SUDs) by mid-2000.

You may also be interested in...



FDA Plans Revisions To Guidance For Categorizing SUD Reprocessing Risks

FDA currently intends to reissue by the end of January its scheme for categorizing the risk of reprocessing single-use devices (SUDs) as a level one guidance document, according to staffers.

FDA Plans Revisions To Guidance For Categorizing SUD Reprocessing Risks

FDA currently intends to reissue by the end of January its scheme for categorizing the risk of reprocessing single-use devices (SUDs) as a level one guidance document, according to staffers.

High-Risk Reprocessed SUD List Under Consideration By Device Center

FDA may opt to create a list of reprocessed single-use devices (SUDs) that it considers to be "high" risk, Center for Devices and Radiological Health Office of Compliance Director Larry Spears reported at a Dec. 14 public meeting in Rockville, Maryland.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel